Painchek Share Price and Company Fundamentals
Last traded: Today at 4:59 AM
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
-
Beta
0.61
Market cap
$54.34M
Enterprise value
$46.28M
Company profile
| Industry / Sector | Health Information Services / Healthcare |
|---|---|
| Website | https://www.painchek.com |
| Mailing address | 35 Lime Street Suite 401 Sydney NSW 2000 Australia |
| Phone / Fax | 61 4 2125 2123 / 61 8 9388 8256 |
Dividends
More: Painchek Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Painchek paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PCK dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Painchek.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A. | MD, CEO & Director | ||
| Mr. Iain McAdam | Chief Financial Officer | ||
| Mr. Andrew Hoggan | Manager & Head of Operations | ||
| Mr. Scott Robertson M.B.A. | Chief Technology Officer | ||
| Prof. Jeff Hughes Ph.D. | Chief Scientific Officer | ||
| Mr. David Allsopp | Head of Business Development of North America | ||
| Mr. Nick Garofoli | Head of Business Development of USA | ||
| Ms. Sasha Grant | Head of Growth for PainChek Infant App | ||
| Ms. Natalie Sylvia Climo L.L.B. | Company Secretary |
Profitability and management effectiveness
Profit margin
-228.18%
Operating margin
-264.90%
Return on assets
-151.46%
Return on equity
-8647.59%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Painchek is 54.34M and its enterprise value is 46.28M. The enterprise value to revenue ratio of PCK is 13.76. The enterprise value to EBITDA ratio of PCK is -6.05.
The PCK's stocks Beta value is 0.61 making it 39% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Painchek (PCK)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Painchek (ASX:PCK) Frequently Asked Questions
1. What is Painchek's Stock Symbol?
Painchek trades on ASX under the ticker symbol "PCK".
2. What is Painchek's stock price today?
One share of PCK stock can currently be purchased for approximately $0.26.
3. How can I contact Painchek?
Painchek's mailing address is 35 Lime Street Suite 401 Sydney NSW 2000 Australia. The company can be reached via phone at 61 4 2125 2123.
4. What is Painchek's official website?
The official website of Painchek is https://www.painchek.com.